ATE406576T1
Method for determining effects of a substance on an organ
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 27 January 2025, 1.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
116 members in 11 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 76816704 | United States of America | A |
Members116
| Document | Office | Kind | |
|---|---|---|---|
| CA2342944A1 | Canada | A1 | |
| WO0018226A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6274899A | Australia | A | |
| WO0018226A3 | World Intellectual Property Organization (WIPO) | A3 | |
| TW442306B | Taiwan Province of China | B | |
| EP1117293A2 | European Patent Office (EPO) | A2 | |
| CN1320014A | China | A | |
| CA2420848A1 | Canada | A1 | |
| WO0226034A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU8677701A | Australia | A | |
| JP2002525290A | Japan | A | |
| WO0226034A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1317175A2 | European Patent Office (EPO) | A2 | |
| US6673594B1 | United States of America | B1 | |
| US2004058432A1 | United States of America | A1 | |
| JP2004513889A | Japan | A | |
| US2004224298A1 | United States of America | A1 | |
| CA2554872A1 | Canada | A1 | |
| WO2005074681A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005074681A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6977140B1 | United States of America | B1 | |
| US2006063142A1 | United States of America | A1 | |
| EP1711816A2 | European Patent Office (EPO) | A2 | |
| CN1985170A | China | A | |
| JP2007519763A | Japan | A | |
| EP1929863A1 | European Patent Office (EPO) | A1 | |
| EP1711816B1 | European Patent Office (EPO) | B1 | |
| AT406576T | Austria | T | |
| ATE406576T1This record | Austria | T1 | |
| DE602005009322D1 | Germany | D1 | |
| ES2314627T3 | Spain | T3 | |
| EP1117293B1 | European Patent Office (EPO) | B1 | |
| DE69941362D1 | Germany | D1 | |
| US7749693B2 | United States of America | B2 | |
| US2010221696A1 | United States of America | A1 | |
| US7824848B2 | United States of America | B2 | |
| EP2258175A2 | European Patent Office (EPO) | A2 | |
| EP2258176A2 | European Patent Office (EPO) | A2 | |
| US2011039253A1 | United States of America | A1 | |
| US2011053256A1 | United States of America | A1 | |
| US2011059429A1 | United States of America | A1 | |
| EP2301334A2 | European Patent Office (EPO) | A2 | |
| EP2301335A2 | European Patent Office (EPO) | A2 | |
| EP2301336A2 | European Patent Office (EPO) | A2 | |
| EP2301337A2 | European Patent Office (EPO) | A2 | |
| EP2301338A2 | European Patent Office (EPO) | A2 | |
| EP2301339A2 | European Patent Office (EPO) | A2 | |
| EP2301340A2 | European Patent Office (EPO) | A2 | |
| EP2301341A2 | European Patent Office (EPO) | A2 | |
| EP2301342A2 | European Patent Office (EPO) | A2 | |
| EP2308291A2 | European Patent Office (EPO) | A2 | |
| EP2308292A2 | European Patent Office (EPO) | A2 | |
| EP2308293A2 | European Patent Office (EPO) | A2 | |
| EP2308294A2 | European Patent Office (EPO) | A2 | |
| EP2308295A2 | European Patent Office (EPO) | A2 | |
| EP2308296A2 | European Patent Office (EPO) | A2 | |
| EP2308295A3 | European Patent Office (EPO) | A3 | |
| US2011129810A1 | United States of America | A1 | |
| US2011129908A1 | United States of America | A1 | |
| EP2308291A3 | European Patent Office (EPO) | A3 | |
| EP2258176A3 | European Patent Office (EPO) | A3 | |
| EP2301334A3 | European Patent Office (EPO) | A3 | |
| EP2301337A3 | European Patent Office (EPO) | A3 | |
| EP2301339A3 | European Patent Office (EPO) | A3 | |
| US2011183310A1 | United States of America | A1 | |
| EP2308292A3 | European Patent Office (EPO) | A3 | |
| EP2301341A3 | European Patent Office (EPO) | A3 | |
| EP2308294A3 | European Patent Office (EPO) | A3 | |
| EP2308296A3 | European Patent Office (EPO) | A3 | |
| EP2301335A3 | European Patent Office (EPO) | A3 | |
| EP2301340A3 | European Patent Office (EPO) | A3 | |
| EP2301342A3 | European Patent Office (EPO) | A3 | |
| US2011300611A1 | United States of America | A1 | |
| US2011300612A1 | United States of America | A1 | |
| US2011300613A1 | United States of America | A1 | |
| US2011300614A1 | United States of America | A1 | |
| US2011300615A1 | United States of America | A1 | |
| EP2258175A3 | European Patent Office (EPO) | A3 | |
| EP2308293A3 | European Patent Office (EPO) | A3 | |
| EP2301338A3 | European Patent Office (EPO) | A3 | |
| EP2301336A3 | European Patent Office (EPO) | A3 | |
| JP2012092111A | Japan | A | |
| JP2012092112A | Japan | A | |
| JP2012092113A | Japan | A | |
| JP2012092114A | Japan | A | |
| JP4958380B2 | Japan | B2 | |
| EP1317175B1 | European Patent Office (EPO) | B1 | |
| US8268547B2 | United States of America | B2 | |
| US8268612B2 | United States of America | B2 | |
| US8318415B2 | United States of America | B2 | |
| US8323954B2 | United States of America | B2 | |
| US8349551B2 | United States of America | B2 | |
| US8420381B2 | United States of America | B2 | |
| US8431385B2 | United States of America | B2 | |
| US2013109006A1 | United States of America | A1 | |
| US8445260B2 | United States of America | B2 | |
| JP5329760B2 | Japan | B2 | |
| US8609400B2 | United States of America | B2 | |
| JP5535180B2 | Japan | B2 | |
| JP5544349B2 | Japan | B2 |
Showing 100 of 116
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5712444
Titles2
- German
- VERFAHREN ZUR BESTIMMUNG DER AUSWIRKUNGEN EINER SUBSTANZ AUF EIN ORGAN
- English
- METHOD FOR DETERMINING THE EFFECTS OF A SUBSTANCE ON AN ORGAN
Classification
- CPC, 3
- G01N33/5082
- A01N1/143
- A01N1/10
- IPC, 2
- A01N1 02
- G01N33 50